Bischoff SC - Search Results

1

Intestinal permeability--a new target for disease prevention and therapy.

Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke JD, Serino M, Tilg H, Watson A, Wells JM. Bischoff SC, et al. BMC Gastroenterol. 2014 Nov 18;14:189. doi: 10.1186/s12876-014-0189-7. BMC Gastroenterol. 2014. PMID: 25407511 Free PMC article. Review.

2

Role of serotonin in fatty acid-induced non-alcoholic fatty liver disease in mice.

Ritze Y, Böhle M, Haub S, Hubert A, Enck P, Zipfel S, Bischoff SC. Ritze Y, et al. Among authors: bischoff sc. BMC Gastroenterol. 2013 Dec 9;13:169. doi: 10.1186/1471-230X-13-169. BMC Gastroenterol. 2013. PMID: 24321090 Free PMC article.

3

'Gut health': a new objective in medicine?

Bischoff SC. Bischoff SC. BMC Med. 2011 Mar 14;9:24. doi: 10.1186/1741-7015-9-24. BMC Med. 2011. PMID: 21401922 Free PMC article.

4

Biomarkers for assessment of intestinal permeability in clinical practice.

Seethaler B, Basrai M, Neyrinck AM, Nazare JA, Walter J, Delzenne NM, Bischoff SC. Seethaler B, et al. Among authors: bischoff sc. Am J Physiol Gastrointest Liver Physiol. 2021 Jul 1;321(1):G11-G17. doi: 10.1152/ajpgi.00113.2021. Epub 2021 May 19. Am J Physiol Gastrointest Liver Physiol. 2021. PMID: 34009040 Free article.

5

Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.

Hafer A, Krämer S, Duncker S, Krüger M, Manns MP, Bischoff SC. Hafer A, et al. Among authors: bischoff sc. BMC Gastroenterol. 2007 Sep 4;7:36. doi: 10.1186/1471-230X-7-36. BMC Gastroenterol. 2007. PMID: 17784949 Free PMC article. Clinical Trial.

6

European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Bischoff SC, Barazzoni R, Busetto L, Campmans-Kuijpers M, Cardinale V, Chermesh I, Eshraghian A, Kani HT, Khannoussi W, Lacaze L, Léon-Sanz M, Mendive JM, Müller MW, Ockenga J, Tacke F, Thorell A, Vranesic Bender D, Weimann A, Cuerda C. Bischoff SC, et al. United European Gastroenterol J. 2022 Sep;10(7):663-720. doi: 10.1002/ueg2.12280. Epub 2022 Aug 12. United European Gastroenterol J. 2022. PMID: 35959597 Free PMC article. Review.

7

Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice.

Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, Bergheim I. Haub S, et al. Among authors: bischoff sc. Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G335-44. doi: 10.1152/ajpgi.00088.2009. Epub 2009 Aug 27. Am J Physiol Gastrointest Liver Physiol. 2010. PMID: 19713474 Free article.

8

Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice.

Haub S, Ritze Y, Ladel I, Saum K, Hubert A, Spruss A, Trautwein C, Bischoff SC. Haub S, et al. Among authors: bischoff sc. J Pharmacol Exp Ther. 2011 Dec;339(3):790-8. doi: 10.1124/jpet.111.181834. Epub 2011 Sep 8. J Pharmacol Exp Ther. 2011. PMID: 21903748

9

Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.

Ritze Y, Bárdos G, Claus A, Ehrmann V, Bergheim I, Schwiertz A, Bischoff SC. Ritze Y, et al. Among authors: bischoff sc. PLoS One. 2014 Jan 27;9(1):e80169. doi: 10.1371/journal.pone.0080169. eCollection 2014. PLoS One. 2014. PMID: 24475018 Free PMC article.

10

Effect of tryptophan supplementation on diet-induced non-alcoholic fatty liver disease in mice.

Ritze Y, Bárdos G, Hubert A, Böhle M, Bischoff SC. Ritze Y, et al. Among authors: bischoff sc. Br J Nutr. 2014 Jul 14;112(1):1-7. doi: 10.1017/S0007114514000440. Epub 2014 Apr 8. Br J Nutr. 2014. PMID: 24708895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page